Compound | CC50 | Simultaneous treatment | Post-treatment | ||
---|---|---|---|---|---|
 | (μM)a | IC50 (μM)b | SIc | IC50 (μM)b | SIc |
1 | 200.8 ± 18.6 | - | - | - | - |
2 | 67.9 ± 13.1 | 28.6 ± 4.3 | 2.3 | 31.4 ± 2.1 | 2.2 |
3 | 50.3 ± 6.2 | 20.4 ± 3.2 | 2.5 | 22.6 ± 1.8 | 2.2 |
4 | 80.0 ± 20.1 | 14.6 ± 2.4 | 5.5 | 18.4 ± 3.1 | 4.3 |
5 | 96.8 ± 15.6 | - | - | - | - |
6 | 106.4 ± 21.2 | 33.8 ± 2.7 | 3.1 | 37.3 ± 3.2 | 2.8 |
7 | 129.5 ± 15.6 | 28.5 ± 2.8 | 4.5 | 31.2 ± 2.2 | 4.1 |
8 | 110.6 ± 17.3 | - | - | - | - |
9 | 160.3 ± 20.4 | - | - | - | - |
10 | 141.6 ± 25.0 | 43.3 ± 5.3 | 3.3 | 42.3 ± 3.9 | 3.4 |
11 | 118.6 ± 19.6 | 38.6 ± 2.9 | 3.1 | 35.2 ± 3.7 | 3.4 |
12 | 115.7 ± 16.8 | - | - | - | - |
Oseltamivir | 598.8 ± 62.1 | 4.9 ± 0.9 | 122.2 | 0.9 ± 0.2 | 665.3 |